CN1857572A - Hypolipidemic health article and its preparing method - Google Patents
Hypolipidemic health article and its preparing method Download PDFInfo
- Publication number
- CN1857572A CN1857572A CN 200610050000 CN200610050000A CN1857572A CN 1857572 A CN1857572 A CN 1857572A CN 200610050000 CN200610050000 CN 200610050000 CN 200610050000 A CN200610050000 A CN 200610050000A CN 1857572 A CN1857572 A CN 1857572A
- Authority
- CN
- China
- Prior art keywords
- health product
- parts
- blood fat
- radix
- fat reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of hypolipidemic health article and its preparation process. The hypolipidemic health article is prepared with ginseng, glossy ganoderma, fleeceflower root, haw, red sage, cassia seed and greenbrier, and through washing, mixing, decocting and filtering. It contains ginseng triterpenoid saponin, ginseng polysaccharide, ganoderic acid, glossy ganoderma polysaccharide, lecithin and amino acids. It has the health functions of nourishing, strengthening physique, delaying senility, removing stasis, promoting tissue regeneration, raising body's immunity, etc.
Description
Technical field
The present invention relates to a kind of blood fat reducing, health product of control cardiovascular and cerebrovascular disease and preparation method thereof health product.
Background technology
Hyperlipemia is the disease that lipid content surpasses normal level in a kind of blood, claims hyperlipoproteinemia again.The composition of blood fat is: cholesterol, triglyceride, phospholipid, free fatty etc.The factor that causes blood fat to increase is a lot, is more common in middle aged body obesity person later on, it is generally acknowledged relevant with factors such as overnutrition, hypokinesia, function decline, psychentonia, lipid metabolic disorder, overweight and heredity.
Primary disease often can cause the heart, brain, angiopathy and cholelithiasis etc.Clinical manifestation differs, and all kinds of xanthoma can be arranged, or symptoms such as hyperlipemia retinopathy, stomachache, early atherosclerosis, obesity, hepatosplenomegaly, blood uric acid increase are arranged.To have caused people's common concern.The control of the heart, brain, angiopathy being included in the control of public health service and infectious disease in China puts on an equal footing.According to investigations, at present, existing 80,000,000 people of China suffer from the heart, brain, angiopathy, become the leading killer of health risk in China qualifiedly.And hyperlipemia is the major incentive with, brain, angiopathy.Thereby the needing that (accent) fat health medicine has become the control heart, brain, angiopathy of falling of developing determined curative effect when affair.
Summary of the invention
The purpose of this invention is to provide a kind of blood fat reducing that has, cholesterol reducing, uric acid resisting, blood sugar lowering, the control heart, brain, angiopathy, and resisting fatigue, anti-hypoxia improves intelligence, improve immunologic function, hemopoietic cell regeneration function and moist skin care, the Chinese medicine health care product of life lengthening.Another object of the present invention provides a kind of preparation method of described Chinese medicine health care product.
The raw material of Chinese medicine health care product of the present invention has Radix Ginseng, Ganoderma, the Radix Polygoni Multiflori, Fructus Crataegi, Radix Salviae Miltiorrhizae, Semen Cassiae, Rhizoma Smilacis Glabrae.The parts by weight proportioning of wherein said each composition is: Radix Ginseng 5-10 part, Ganoderma 10-20 part, Radix Polygoni Multiflori 15-35 part, Fructus Crataegi 10-25 part, Radix Salviae Miltiorrhizae 10-25 part, Cortex Lycii 10-35 part, Rhizoma Smilacis Glabrae 25-45 part.
Preferably: 8 parts of Radix Ginsengs, 15 parts of Ganodermas, 25 parts of the Radixs Polygoni Multiflori, 20 parts of Fructus Crataegis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Semen Cassiaes, 35 parts of Rhizoma Smilacis Glabraes.
Wherein said Radix Ginseng has strongly invigorating primordial QI, the tonifying the lung spleen invigorating, and promoting the production of body fluid to quench thirst, Fructus Alpiniae Oxyphyllae is reposed, and reduces cholesterol, triacylglycerol in blood and the liver, reduces serum low-density LP and does not influence high density lipoprotein.The ginseng polysaccharide also has the reduction effect to hyperglycemia.
Described Ganoderma has strengthening by means of tonics, detoxifcation convergence, eliminate indigestion, blood pressure lowering, and blood fat reducing and the formation of prevention of arterial atherosclerotic plaque.Ganoderma is blood fat reducing and cholesterol, beta lipoprotein and triacylglycerol and to the protective effect of myocardial ischemia obviously, and increase myocardial oxygen delivery, thereby increase cardiac function, and the effect of protecting liver and detoxication.
The described Radix Polygoni Multiflori has nourishing YIN and nourishes blood, loosening bowel to relieve constipation, detoxifcation, and slow down aging, blood fat reducing, the effect of arteriosclerosis.
Described Fructus Crataegi has promoting digestion and invigorating the stomach, and blood circulation promoting and blood stasis dispelling, and heart tonifying dilating coronary blood vessel increase coronary flow, to ischemic myocardial protection, reduces blood viscosity and blood fat reducing, delaying senility function.
Described Radix Salviae Miltiorrhizae has promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, and the clear pain of removing heat from blood, clearing away heart-fire for tranquillization, and resist myocardial ischemia or the effect of heart infarction.Improve immunologic function, have antiinflammatory, antitumor protects the liver, the effect of hepatoprotective.
Described Semen Cassiae has liver heat removing and eyesight improving, loosening bowel to relieve constipation, and blood pressure lowering, effect for reducing blood fat.
Described Rhizoma Smilacis Glabrae has dehumidifying, arrange turbid, detoxifcation, easing joint movement, and antitumor, atherosclerosis resists myocardial ischemia, anti-inflammatory and antalgic, and diuretic actions.
The preparation method of Chinese medicine health care product of the present invention comprises, with selected Radix Ginseng, Ganoderma, the Radix Polygoni Multiflori, Fructus Crataegi, Radix Salviae Miltiorrhizae, Semen Cassiae, Rhizoma Smilacis Glabrae cleaning after-filtration, mixes, and through decocting, overanxious removing slag gets final product again.
Chinese medicine health care product of the present invention can also comprise that the liquid sample that will obtain further is processed as the ball lamellar.
Chinese medicine health care product of the present invention can also comprise that the liquid sample that will obtain further is processed as graininess and electuary.Chinese medicine health care product of the present invention can also comprise that the liquid sample that will obtain further is processed as powdery and capsule.
The natural components of Chinese medicine health care product of the present invention contains Radix Ginseng triterpene saponin, ginseng polysaccharide, Ganodenic acid, ganoderan, lecithin, each seed amino acid.Have coronary blood flow increasing, improve the myocardial nutritional flow supply, improve immune function of human body, hemopoietic cell regeneration and resisting fatigue, anti-hypoxia.Be used to bring high blood pressure down, blood lipid regulation reduces serum cholesterol.Prevention of arterial is atherosis and moisten skin care, effect of prolonging life.
Chinese medicine health care product of the present invention makes full use of China's national tradition theory of Chinese medical science and puts in order out, collection body-building health, control combination, multiple function.Prescription adopts the pharmacology composition of the Nature Chinese herbal medicine fully, is real green pure natural health-care product.
Preparation method of the present invention is scientific and reasonable, and is simple, and raw material is from natural Chinese medicinal ingredients, and is nontoxic, harmless, have no side effect, and the source is sufficient.After the course of treatment of medication (15-20 days), blood fat, cholesterol, uric acid significantly descend.Somatosensory is good, and is in high spirits, sleeps, and health is light.Two just moisten freely, do not have any bad reflection.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.
Embodiment one
Selected and take by weighing raw material (unit kilogram) by following proportioning:
Radix Ginseng 5 Ganodermas 10 Radixs Polygoni Multiflori 15 Fructus Crataegis 10 Radix Salviae Miltiorrhizaes 10
Semen Cassiae 10 Rhizoma Smilacis Glabraes 25
Production method is as follows:
With the above-mentioned raw material that takes by weighing, sieve after washing respectively earlier, remix decocts, and filter and remove residue obtains 2 times of concentrated solutions to the raw material gross weight.
Instructions of taking: 80 grams/time, day clothes 2 times, taking medicine before meal is used sooner or later.
Embodiment two
Selected and take by weighing raw material (unit kilogram) by following proportioning:
Radix Ginseng 8 Ganodermas 15 Radixs Polygoni Multiflori 25 Fructus Crataegis 20 Radix Salviae Miltiorrhizaes 20
Semen Cassiae 20 Rhizoma Smilacis Glabraes 35
Production method is as follows:
With the above-mentioned raw material that takes by weighing, sieve after washing respectively earlier, remix decocts, and filter and remove residue obtains 2 times of concentrated solutions to the raw material gross weight.Again concentrated solution further is processed as pill or tablet.
Embodiment three
Selected and take by weighing raw material (unit kilogram) by following proportioning:
Radix Ginseng 10 Ganodermas 20 Radixs Polygoni Multiflori 35 Fructus Crataegis 25 Radix Salviae Miltiorrhizaes 25
Semen Cassiae 35 Rhizoma Smilacis Glabraes 45
Production method is as follows:
With the above-mentioned raw material that takes by weighing, sieve after washing respectively earlier, remix decocts, and filter and remove residue obtains 2 times of concentrated solutions to the raw material gross weight.Again concentrated solution further is processed as the graininess electuary.
Claims (8)
1, a kind of health product of blood fat reducing is characterized in that its raw material contains Radix Ginseng, Ganoderma, the Radix Polygoni Multiflori, Fructus Crataegi, Radix Salviae Miltiorrhizae, Semen Cassiae, Rhizoma Smilacis Glabrae.
2, the health product of a kind of blood fat reducing according to claim 1 is characterized in that the parts by weight proportioning of wherein said each composition is: Radix Ginseng 5-10 part, Ganoderma 10-20 part, Radix Polygoni Multiflori 15-35 part, Fructus Crataegi 10-25 part, Radix Salviae Miltiorrhizae 10-25 part, Semen Cassiae 10-35 part, Rhizoma Smilacis Glabrae 25-45 part.
3, the health product of a kind of blood fat reducing according to claim 2 is characterized in that the parts by weight proportioning of wherein said each composition is: 8 parts of Radix Ginsengs, 15 parts of Ganodermas, 25 parts of the Radixs Polygoni Multiflori, 20 parts of Fructus Crataegis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Cortex Lycii, 35 parts of Rhizoma Smilacis Glabraes.
4, according to the health product of any one described a kind of blood fat reducing of claim 1-3, the dosage form that it is characterized in that described health product is a decoction.
5, according to the health product of any one described a kind of blood fat reducing of claim 1-3, the dosage form that it is characterized in that described health product is pill or tablet.
6, according to the health product of any one described a kind of blood fat reducing of claim 1-3, the dosage form that it is characterized in that described health product is a granule.
7, according to the health product of any one described a kind of blood fat reducing of claim 1-3, the dosage form that it is characterized in that described health product is a powder.
8, the preparation method of the health product of a kind of blood fat reducing according to claim 4 is characterized in that and will filter, mix after selected Radix Ginseng, Ganoderma, the Radix Polygoni Multiflori, Fructus Crataegi, Radix Salviae Miltiorrhizae, Semen Cassiae, the Rhizoma Smilacis Glabrae cleaning that through decocting, filter and remove residue gets final product again.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610050000 CN1857572A (en) | 2006-03-24 | 2006-03-24 | Hypolipidemic health article and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610050000 CN1857572A (en) | 2006-03-24 | 2006-03-24 | Hypolipidemic health article and its preparing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1857572A true CN1857572A (en) | 2006-11-08 |
Family
ID=37296560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610050000 Withdrawn CN1857572A (en) | 2006-03-24 | 2006-03-24 | Hypolipidemic health article and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1857572A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102805780A (en) * | 2012-08-26 | 2012-12-05 | 郭碧峰 | Health-care tea for treating gout and preparation method thereof |
| CN103416746A (en) * | 2013-07-16 | 2013-12-04 | 湖北恩施聚硒康农业科技有限公司 | Lipid-lowing selenium-rich tea pigment and production method thereof |
| CN104189631A (en) * | 2014-07-28 | 2014-12-10 | 王永远 | Traditional Chinese medicine composition with effect of reducing weight and lowering lipid and preparation method thereof |
| CN105148133A (en) * | 2015-09-30 | 2015-12-16 | 杭州麟莱进出口有限公司 | Traditional Chinese medicine tea for treating hypertension, hyperlipidemia, hyperglycemia and hyperuricemia |
| CN105341613A (en) * | 2015-12-02 | 2016-02-24 | 青岛浩大海洋保健食品有限公司 | Solid shark fin bone powder beverage capable of reducing blood lipid and complementing calcium for mid-aged people and aged people and preparation technology of solid shark fin bone powder beverage |
| CN107373227A (en) * | 2017-07-31 | 2017-11-24 | 何家平 | A kind of beverage of reducing blood lipid and preparation method thereof |
-
2006
- 2006-03-24 CN CN 200610050000 patent/CN1857572A/en not_active Withdrawn
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102805780A (en) * | 2012-08-26 | 2012-12-05 | 郭碧峰 | Health-care tea for treating gout and preparation method thereof |
| CN102805780B (en) * | 2012-08-26 | 2014-12-03 | 郭碧峰 | Health-care tea for treating gout and preparation method thereof |
| CN103416746A (en) * | 2013-07-16 | 2013-12-04 | 湖北恩施聚硒康农业科技有限公司 | Lipid-lowing selenium-rich tea pigment and production method thereof |
| CN103416746B (en) * | 2013-07-16 | 2014-09-24 | 湖北恩施聚硒康农业科技有限公司 | Lipid-lowing selenium-rich tea pigment and production method thereof |
| CN104189631A (en) * | 2014-07-28 | 2014-12-10 | 王永远 | Traditional Chinese medicine composition with effect of reducing weight and lowering lipid and preparation method thereof |
| CN105148133A (en) * | 2015-09-30 | 2015-12-16 | 杭州麟莱进出口有限公司 | Traditional Chinese medicine tea for treating hypertension, hyperlipidemia, hyperglycemia and hyperuricemia |
| CN105148133B (en) * | 2015-09-30 | 2018-10-09 | 杭州麟莱进出口有限公司 | One kind controlling four high Tea containing traditional Chinese medicines |
| CN105341613A (en) * | 2015-12-02 | 2016-02-24 | 青岛浩大海洋保健食品有限公司 | Solid shark fin bone powder beverage capable of reducing blood lipid and complementing calcium for mid-aged people and aged people and preparation technology of solid shark fin bone powder beverage |
| CN107373227A (en) * | 2017-07-31 | 2017-11-24 | 何家平 | A kind of beverage of reducing blood lipid and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1047946C (en) | Preparation for treating senile diseases | |
| CN1437959A (en) | Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| CN1475229A (en) | Antifatigue compound Chinese medicine prescription and its preparation method | |
| CN101274042A (en) | Medicament composition for curing hyperlipemia and method of preparing the same | |
| CN1857572A (en) | Hypolipidemic health article and its preparing method | |
| CN104757669B (en) | A kind of hypertension and hyperlipemia health beverage and preparation method thereof | |
| CN101062329A (en) | Chinese traditional medicine massaging ointment for losing weight and the preparing method thereof | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN1275634C (en) | Health tea capable of reducing blood lipid, blood viscosity and blood pressure | |
| CN1685972A (en) | Antisenility health care food | |
| CN101020013A (en) | Hypoglycemic and antilipemic health product and its prepn | |
| CN102198217B (en) | Skin-caring anti-aging traditional Chinese medicine composition, preparation method thereof and application thereof | |
| CN1211434A (en) | Oral liquid for resisting altitude stress and its preparation method | |
| CN1305816A (en) | Medicine for treating diabetes | |
| CN103721187A (en) | Blood-circulation-promoting and blood-fat-reducing pill for treating hyperlipemia and preparation method of pill | |
| CN100413521C (en) | Health product for reducing blood fat, and preparation method | |
| CN1056287C (en) | Traditional Chinese medicine for reducing blood-lipid and its preparing technology | |
| CN103405574B (en) | Medicinal composition for treating hypertension | |
| CN1651037A (en) | Spleen fortifying food dispersing oral liquid and its preparation method | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1280835A (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN1070073C (en) | Medicine for treating hypercoagulable blood and its preparing process | |
| CN1185007C (en) | Blood-lipid-reducing thrombolytic medicine | |
| CN1215873C (en) | Chinese Medicine compound preparation for treating fatty liver and its making method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |